news
Omada Program Shows GLP-1 Patients Preserve Lean Muscle Over Twelve Weeks
Data from Omada Health's GLP-1 Care Track revealed that patients on their behavioral protocol lost more overall weight while increasing their proportion of lean muscle compared to standard care over 12 weeks. The digital clinic paired weekly GLP-1 medication with targeted strength habits and protein tracking. It offers rare clinical confirmation that intentional resistance work prevents the rapid lean tissue loss common on these drugs.
Data from Omada Health's GLP-1 Care Track revealed that patients on their behavioral protocol lost more overall weight while increasing their proportion of lean muscle compared to standard care over 12 weeks. The digital clinic paired weekly GLP-1 medication with targeted strength habits and protein tracking. It offers rare clinical confirmation that intentional resistance work prevents the rapid lean tissue loss common on these drugs.
The architecture take
I used to think the GLP-1 muscle loss panic was slightly overblown by gym bros trying to protect their turf. I was wrong. When you drop weight fast without a plan, up to forty percent of that loss can come straight from lean tissue, which tanks your resting metabolic rate and leaves you metabolically fragile when you eventually stop the injections. Omada's twelve-week data makes the obvious point that telehealth platforms have spent two years ignoring: the drug's only half the prescription. If you aren't actively tracking protein intake and resistance training alongside the weekly jab, you are effectively trading visceral fat for sarcopenia. My friend Sarah lost twenty pounds on semaglutide last winter and ended up too exhausted to carry her own groceries up two flights of stairs. That is not metabolic health. The next wave of GLP-1 care will live or die on body composition metrics, not just scale weight. I want to see DEXA scans become standard protocol.